[go: up one dir, main page]

IT1319655B1 - Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. - Google Patents

Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.

Info

Publication number
IT1319655B1
IT1319655B1 IT2000MI002456A ITMI20002456A IT1319655B1 IT 1319655 B1 IT1319655 B1 IT 1319655B1 IT 2000MI002456 A IT2000MI002456 A IT 2000MI002456A IT MI20002456 A ITMI20002456 A IT MI20002456A IT 1319655 B1 IT1319655 B1 IT 1319655B1
Authority
IT
Italy
Prior art keywords
microspheres
high stability
pancreatic enzyme
relative preparation
pancreatic enzymes
Prior art date
Application number
IT2000MI002456A
Other languages
English (en)
Inventor
Mario Maio
Original Assignee
Eurand Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11446110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IT1319655(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eurand Int filed Critical Eurand Int
Priority to IT2000MI002456A priority Critical patent/IT1319655B1/it
Priority to US10/416,702 priority patent/US9259393B2/en
Priority to ES01994654T priority patent/ES2240559T3/es
Priority to DE60110106T priority patent/DE60110106T2/de
Priority to CA002428837A priority patent/CA2428837A1/en
Priority to KR10-2003-7006513A priority patent/KR20030060105A/ko
Priority to AT01994654T priority patent/ATE292959T1/de
Priority to EP01994654A priority patent/EP1335706B1/en
Priority to AU2002224843A priority patent/AU2002224843A1/en
Priority to PCT/EP2001/013115 priority patent/WO2002040045A2/en
Priority to JP2002542417A priority patent/JP4555981B2/ja
Publication of ITMI20002456A1 publication Critical patent/ITMI20002456A1/it
Publication of IT1319655B1 publication Critical patent/IT1319655B1/it
Application granted granted Critical
Priority to US14/953,638 priority patent/US9884025B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT2000MI002456A 2000-11-15 2000-11-15 Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. IT1319655B1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT2000MI002456A IT1319655B1 (it) 2000-11-15 2000-11-15 Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
AT01994654T ATE292959T1 (de) 2000-11-15 2001-11-13 Verfahren zur herstellung von pankreasenzym enthaltende mikrosphären mit hoher stabilität
AU2002224843A AU2002224843A1 (en) 2000-11-15 2001-11-13 Microspheres of pancreatic enzymes with high stability
DE60110106T DE60110106T2 (de) 2000-11-15 2001-11-13 Verfahren zur herstellung von pankreasenzym enthaltende mikrosphären mit hoher stabilität
CA002428837A CA2428837A1 (en) 2000-11-15 2001-11-13 Microspheres of pancreatic enzymes with high stability
KR10-2003-7006513A KR20030060105A (ko) 2000-11-15 2001-11-13 안정성이 높은 췌장 효소 마이크로스피어 및 그 제조방법
US10/416,702 US9259393B2 (en) 2000-11-15 2001-11-13 Microspheres of pancreatic enzymes with high stability and production method thereof
EP01994654A EP1335706B1 (en) 2000-11-15 2001-11-13 Process fo r the production of microspheres of pancreatic enzymes with high stability
ES01994654T ES2240559T3 (es) 2000-11-15 2001-11-13 Proceso de fabricacion de microsferas de enzimas pancreaticas con una alta estabilidad.
PCT/EP2001/013115 WO2002040045A2 (en) 2000-11-15 2001-11-13 Microspheres of pancreatic enzymes with high stability
JP2002542417A JP4555981B2 (ja) 2000-11-15 2001-11-13 高い安定性を有する膵臓酵素の極小球体とその製造方法
US14/953,638 US9884025B2 (en) 2000-11-15 2015-11-30 Microspheres of pancreatic enzymes with high stability and production method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI002456A IT1319655B1 (it) 2000-11-15 2000-11-15 Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.

Publications (2)

Publication Number Publication Date
ITMI20002456A1 ITMI20002456A1 (it) 2002-05-15
IT1319655B1 true IT1319655B1 (it) 2003-10-23

Family

ID=11446110

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI002456A IT1319655B1 (it) 2000-11-15 2000-11-15 Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.

Country Status (11)

Country Link
US (2) US9259393B2 (it)
EP (1) EP1335706B1 (it)
JP (1) JP4555981B2 (it)
KR (1) KR20030060105A (it)
AT (1) ATE292959T1 (it)
AU (1) AU2002224843A1 (it)
CA (1) CA2428837A1 (it)
DE (1) DE60110106T2 (it)
ES (1) ES2240559T3 (it)
IT (1) IT1319655B1 (it)
WO (1) WO2002040045A2 (it)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632429B1 (en) * 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US8100844B2 (en) * 2002-04-25 2012-01-24 Ultraflex Systems, Inc. Ambulating ankle and knee joints with bidirectional dampening and assistance using elastomeric restraint
DE602005009677D1 (de) * 2004-03-22 2008-10-23 Solvay Pharm Gmbh Orale pharmazeutische zusammensetzungen von produkten mit lipase, insbesondere von pankreatin, mit tensiden
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
US20070148151A1 (en) 2005-07-29 2007-06-28 Martin Frink Processes for the manufacture and use of pancreatin
WO2007020260A2 (en) * 2005-08-15 2007-02-22 Solvay Pharmaceuticals Gmbh Pancreatin micropellet cores suitable for enteric coating
DE602006012346D1 (de) * 2005-08-15 2010-04-01 Solvay Pharm Gmbh Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel
SI1931316T1 (sl) * 2005-08-15 2010-06-30 Solvay Pharm Gmbh Farmacevtski sestavki z nadzorovanim sproščanjem za kislinsko labilna zdravila
NZ565959A (en) * 2005-08-15 2011-10-28 Solvay Pharm Gmbh Pancreatin micropellet cores suitable for enteric coating
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US20070116695A1 (en) * 2005-09-21 2007-05-24 Fallon Joan M Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
RU2445952C2 (ru) * 2007-02-20 2012-03-27 Юранд Фармасьютикалз Лимитед Стабильные композиции пищеварительных ферментов
DK2079445T3 (en) * 2007-02-20 2016-02-15 Allergan Pharmaceuticals Internat Ltd Stable digestive compositions
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US20090324730A1 (en) * 2008-06-26 2009-12-31 Fallon Joan M Methods and compositions for the treatment of symptoms of complex regional pain syndrome
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
EP2318035B1 (en) * 2008-07-01 2019-06-12 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) * 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
CN105664144B (zh) 2009-01-06 2020-08-11 加尔纳根有限责任公司 治疗或预防金黄色葡萄球菌感染以及根除或减少表面上金黄色葡萄球菌的组合物和方法
KR101694931B1 (ko) 2009-01-06 2017-01-10 큐어론 엘엘씨 이. 콜라이에 의한 구강 감염의 치료 또는 예방을 위한 조성물 및 방법
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
JP2013515783A (ja) * 2009-12-29 2013-05-09 インパックス ラボラトリーズ，インコーポレーテッド 膨潤性親水性ポリマーを用いた胃滞留型固体経口投与剤形
RU2012148776A (ru) * 2010-05-03 2014-06-10 Апталис Фарма Лтд. Композиции из микропеллет, включающие панкреатин, содержащий смесь пищеварительных ферментов
EA029101B1 (ru) 2010-10-01 2018-02-28 Апталис Фарма Лимитид Составы с низкой дозой панкрелипазы и кишечнорастворимым покрытием
US20140147500A1 (en) * 2010-11-19 2014-05-29 Joan M. Fallon Preparation and Use of Combination Enzyme and Gastrointestinal Modulator Delivery Systems
WO2012145651A2 (en) 2011-04-21 2012-10-26 Curemark, Llc Compounds for the treatment of neuropsychiatric disorders
RU2602183C2 (ru) 2011-08-08 2016-11-10 Апталис Фарма Лтд. Способ проведения теста на растворение твердых композиций, содержащих пищеварительные ферменты
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
CN104981236B (zh) 2012-09-27 2019-01-22 珠海圣美生物诊断技术有限公司 刺激敏感性微粒和使用方法
RU2679832C2 (ru) 2013-08-09 2019-02-13 Аллерган Фармасьютикалз Интернэйшнл Лимитед Композиция пищеварительных ферментов, подходящая для энтерального введения
EP3157568A1 (en) 2014-06-19 2017-04-26 Aptalis Pharma Limited Methods for removing viral contaminants from pancreatic extracts
TR201704471T1 (tr) 2014-11-05 2018-04-24 Abbott Gmbh & Co Kg Pankreatin İhtiva Eden İyileştirilmiş Güvenlik Profiline Sahip Bileşimlerin Üretilmesi İçin Prosesler Ve Farmasötik Kullanıma Uygun Bileşimler
EP3609528A4 (en) 2017-04-10 2020-12-23 Curemark, LLC COMPOSITIONS FOR THE TREATMENT OF ADDICTION
CN110075279A (zh) * 2019-04-25 2019-08-02 淮安麦德森制药有限公司 胰酶微球及其生产方法
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
CN113046233B (zh) * 2021-03-15 2022-07-15 中国科学院过程工程研究所 一种微球-膜集成酶反应器及其制备方法和应用
US12350641B2 (en) * 2021-07-16 2025-07-08 Clearh2O, Inc. Methods of high throughput hydrocolloid bead production and apparatuses thereof

Family Cites Families (121)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1342409A (en) 1970-07-23 1974-01-03 Ciba Geigy Ag Flowable pancreatin preparation of low microorgan ism content and a process for its manufacture
GB1509866A (en) 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
US4237229A (en) 1975-06-10 1980-12-02 W. R. Grace & Co. Immobilization of biological material with polyurethane polymers
GB1590432A (en) 1976-07-07 1981-06-03 Novo Industri As Process for the production of an enzyme granulate and the enzyme granuate thus produced
JPS5535031A (en) 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
DE2923279C2 (de) * 1979-06-08 1987-07-09 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von Pankreatin-Pellets und diese enthaltende Arzneimittel
JPS5855125B2 (ja) 1980-03-10 1983-12-08 信越化学工業株式会社 固形薬剤用腸溶性コ−テイング剤組成物
JPS5885159A (ja) 1981-11-17 1983-05-21 Furointo Sangyo Kk 溶出試験装置
DE3377506D1 (en) 1982-12-30 1988-09-01 Nordmark Arzneimittel Gmbh Process for obtaining pancreatin
US4447412A (en) 1983-02-01 1984-05-08 Bilton Gerald L Enzyme-containing digestive aid compostions
US4704295A (en) 1983-09-19 1987-11-03 Colorcon, Inc. Enteric film-coating compositions
DE3445301A1 (de) 1984-12-12 1986-06-12 Hoechst Ag, 6230 Frankfurt Pankreasenzympraeparate und verfahren zu deren herstellung
WO1987004184A1 (fr) 1985-12-27 1987-07-16 Showa Denko Kabushiki Kaisha Procede de granulation d'enzyme
US4849227A (en) 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
AU608756B2 (en) 1986-03-21 1991-04-18 Eurasiam Laboratories, Inc. Compositions for the oral administration of biologically active materials
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
IT1205716B (it) 1987-01-21 1989-03-31 Samil Spa Procedimento per la preparazione di microsfere gastroresistenti ed enterosolubili di enzima digestivo e preparato faramceutico a microsfere cosi' prodotto
DK435687D0 (da) 1987-08-21 1987-08-21 Novo Industri As Enzymholdigt granulat og fremgangsmaade til fremstilling deraf
JPH0757312B2 (ja) * 1987-12-11 1995-06-21 昭和電工株式会社 造粒用バインダー
JP2598674B2 (ja) * 1988-05-06 1997-04-09 昭和電工株式会社 酵素含有水溶性マイクロカプセルの製造法
US5733763A (en) 1988-08-19 1998-03-31 Novo Nordisk A/S Enzyme granulate formed of an enzyme-containing core and an enzyme-containing shell
DK78189D0 (da) 1989-02-20 1989-02-20 Novo Industri As Enzymholdigt granulat og fremgangsmaade til fremstilling deraf
DK78089D0 (da) 1989-02-20 1989-02-20 Novo Industri As Detergentholdigt granulat og fremgangsmaade til fremstilling deraf
DK306289D0 (da) 1989-06-21 1989-06-21 Novo Nordisk As Detergentadditiv i granulatform
PH30058A (en) 1989-11-24 1996-11-08 Biochemie Gmbh Pancreation preparations
IT1246350B (it) 1990-07-11 1994-11-17 Eurand Int Metodo per ottenere una rapida sospensione in acqua di farmaci insolubili
JP3055799B2 (ja) * 1990-11-21 2000-06-26 塩野義製薬株式会社 パンクレアチン含有組成物
DK0565522T3 (da) * 1990-12-31 1997-12-15 Pioneer Hi Bred Int Tørrede, på en roterende skive med fedtsyre mikroindkapslede bakterier
JPH0790565B2 (ja) 1991-08-06 1995-10-04 株式会社日本製鋼所 樹脂成形プレスのスライド制御方法及びその装置
US5225202A (en) 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
WO1993007859A1 (en) 1991-10-23 1993-04-29 Warner-Lambert Company Novel pharmaceutical pellets and process for their production
SE9200858L (sv) 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
US5616483A (en) 1992-06-11 1997-04-01 Aktiebolaget Astra Genomic DNA sequences encoding human BSSL/CEL
US5460812A (en) 1992-06-22 1995-10-24 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5578304A (en) 1992-06-22 1996-11-26 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
US5260074A (en) 1992-06-22 1993-11-09 Digestive Care Inc. Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
DE4227385A1 (de) * 1992-08-19 1994-02-24 Kali Chemie Pharma Gmbh Pankreatinmikropellets
JP3264027B2 (ja) 1993-02-24 2002-03-11 ソニー株式会社 放電セル及びその製造方法
JP2865548B2 (ja) * 1994-03-08 1999-03-08 澁谷油脂株式会社 流動性洗浄用粉粒体およびその製造法
US5955448A (en) 1994-08-19 1999-09-21 Quadrant Holdings Cambridge Limited Method for stabilization of biological substances during drying and subsequent storage and compositions thereof
DE4422433A1 (de) 1994-06-28 1996-01-04 Cognis Bio Umwelt Mehrenzymgranulat
EP0768980B1 (en) 1994-08-05 2001-11-07 West Pharmaceutical Services Cornwall Limited Container for moisture sensitive material and corresponding desiccating and reducing methods
US5733575A (en) 1994-10-07 1998-03-31 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
CA2222682A1 (en) 1995-05-31 1996-12-05 Medzyme N.V. Composition to improve digestibility and utilisation of nutrients
US6057139A (en) 1995-06-29 2000-05-02 Mcneil-Ppc, Inc. Preblend of microcrystalline cellulose and lactase for making tablets
JP3510387B2 (ja) * 1995-06-30 2004-03-29 ライオン株式会社 漂白活性化剤造粒物の製造方法、該漂白活性化剤造粒物を含有する漂白剤又は洗剤の製造方法
US5665428A (en) * 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
US5750104A (en) 1996-05-29 1998-05-12 Digestive Care Inc. High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
DE19622131A1 (de) 1996-06-01 1997-12-04 Solvay Enzymes Gmbh & Co Kg Neue Enzymgranulate
EP0938657A4 (en) 1996-06-04 1999-10-27 Euro Celtique Sa IMPROVEMENTS OF DETECTION SYSTEMS AND METHOD FOR PREDICTING THE RESOLUTION CURVE OF A MEDICINE OF A PHARMACEUTICAL DOSAGE FORM
JPH1023888A (ja) 1996-07-10 1998-01-27 Kao Corp 酵素造粒物の製造方法
US8828432B2 (en) 1996-10-28 2014-09-09 General Mills, Inc. Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
GB9623205D0 (en) 1996-11-07 1997-01-08 Eurand Int Novel pharmaceutical compositions
US5861291A (en) 1997-02-24 1999-01-19 Biozymes Inc. Method for producing pancreatin which contains low amounts of residual organic solvent and product thereof
JPH10295374A (ja) 1997-04-30 1998-11-10 Amano Pharmaceut Co Ltd 安定な酵素顆粒の製造法
DE19721467A1 (de) * 1997-05-22 1998-11-26 Basf Ag Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
SE9702338D0 (sv) 1997-06-18 1997-06-18 Astra Ab An analytical method and industrial process including the same
ES2137862B1 (es) 1997-07-31 2000-09-16 Intexim S A Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
JP3611456B2 (ja) 1997-09-30 2005-01-19 日研化学株式会社 テオフィリン徐放性錠剤
KR19990072826A (ko) 1998-02-26 1999-09-27 우재영 판크레아틴장용코팅과립의제조방법
US7201923B1 (en) 1998-03-23 2007-04-10 General Mills, Inc. Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
US20010024660A1 (en) 1999-09-29 2001-09-27 Ismat Ullah Enteric coated pharmaceutical composition and method of manufacturing
US7122207B2 (en) 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
JP3071427B2 (ja) * 1998-10-09 2000-07-31 花王株式会社 酵素粒子
RU2236847C2 (ru) 1998-11-02 2004-09-27 Илан Корпорейшн, Плк. Композиции в виде множества частиц с модифицированным высвобождением
AU7405400A (en) * 1999-10-01 2001-05-10 Novozymes A/S Enzyme granulate
US20010046493A1 (en) 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
WO2001070047A1 (en) 2000-03-24 2001-09-27 Société des Produits Nestlé S.A. Nutritional composition comprising hydrolysed protein
AU2001244093A1 (en) 2000-04-03 2001-10-15 Novozymes A/S Enzyme tablets for cleaning improvement
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
AR032392A1 (es) 2001-01-19 2003-11-05 Solvay Pharm Gmbh Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
AUPR272901A0 (en) 2001-01-25 2001-02-22 Gainful Plan Limited Method of preparing biological materials and preparations produced using same
ATE346590T1 (de) 2001-07-26 2006-12-15 Ethypharm Sa Umgehüllte allylamine oder benzylamine enthaltende granulate, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die umgehüllten granulate
JP4187085B2 (ja) 2001-08-24 2008-11-26 三菱電機株式会社 車両用乗員保護装置
US20040197321A1 (en) 2002-03-19 2004-10-07 Tibor Sipos Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
CN1156308C (zh) 2002-04-19 2004-07-07 北京世诺医药科技有限公司 多酶组合胶囊
US20040121010A1 (en) 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
WO2004049820A1 (ja) 2002-11-29 2004-06-17 Freund Corporation 水性セラック皮膜剤、その製造方法、該皮膜剤を用いたコーテッド食品、その製造方法、コーテッド医薬品、その製造方法、油性菓子の艶付用組成物、艶付方法、及び艶付油性菓子
CA2419572A1 (en) 2003-02-18 2004-08-18 Axcan Pharma Inc. High dosage protease formulation
US20040213847A1 (en) 2003-04-23 2004-10-28 Matharu Amol Singh Delayed release pharmaceutical compositions containing proton pump inhibitors
JP2007509982A (ja) 2003-10-29 2007-04-19 アルタス ファーマシューティカルズ インコーポレイテッド 血漿コレシストキニン（ｃｃｋ）濃度を制御するための非膵臓プロテアーゼおよび痛みを処置するための非膵臓プロテアーゼ
US7670624B2 (en) 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
DE602005009677D1 (de) 2004-03-22 2008-10-23 Solvay Pharm Gmbh Orale pharmazeutische zusammensetzungen von produkten mit lipase, insbesondere von pankreatin, mit tensiden
US20050281876A1 (en) 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
US20060198838A1 (en) 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
RU2385736C2 (ru) 2004-10-14 2010-04-10 Элтус Фармасьютикалз Инк. Композиции, содержащие липазу, протеазу и амилазу, предназначенные для лечения недостаточности поджелудочной железы
US20070025977A1 (en) 2005-07-21 2007-02-01 Mulberg Andrew E Method of treating steatorrhea in infants
KR101199196B1 (ko) 2005-07-25 2012-11-07 (주)다산메디켐 구형의 판크레아틴 과립의 제조방법
US20070148151A1 (en) 2005-07-29 2007-06-28 Martin Frink Processes for the manufacture and use of pancreatin
SI1931316T1 (sl) 2005-08-15 2010-06-30 Solvay Pharm Gmbh Farmacevtski sestavki z nadzorovanim sproščanjem za kislinsko labilna zdravila
WO2007020260A2 (en) 2005-08-15 2007-02-22 Solvay Pharmaceuticals Gmbh Pancreatin micropellet cores suitable for enteric coating
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
WO2007053619A2 (en) 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
US20070141151A1 (en) 2005-12-20 2007-06-21 Silver David I Lansoprazole orally disintegrating tablets
US8486450B2 (en) 2005-12-28 2013-07-16 Takeda Pharmaceutical Company Limited Method of producing solid preparation disintegrating in the oral cavity
WO2007085024A2 (en) 2006-01-21 2007-07-26 Abbott Gmbh & Co. Kg Dosage form and method for the delivery of drugs of abuse
BRPI0712087A2 (pt) 2006-05-26 2012-07-17 Nestec Ag métodos de uso e composições nutricionais de extrato de rouchi
WO2008017659A1 (en) 2006-08-07 2008-02-14 Novozymes A/S Enzyme granules for animal feed
KR100804096B1 (ko) 2006-08-31 2008-02-18 (주)아모레퍼시픽 고농도 계면활성제 계에서도 안정한 효소 캡슐 제제를포함하는 피부 세정용 조성물 및 그 제조방법
US20080199448A1 (en) 2007-02-16 2008-08-21 Ross Mairi R Enzyme composition for improving food digestion
DK2079445T3 (en) 2007-02-20 2016-02-15 Allergan Pharmaceuticals Internat Ltd Stable digestive compositions
US20090117180A1 (en) 2007-02-20 2009-05-07 Giovanni Ortenzi Stable digestive enzyme compositions
WO2008127567A1 (en) 2007-04-13 2008-10-23 Beth Israel Deaconess Medical Center, Inc. Novel nutritional food products for improved digestion and intestinal absorption
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
CN101430279A (zh) 2008-10-27 2009-05-13 江南大学 荧光分光光度法筛选催化非水相体系转酯化反应用酶的方法
US8784884B2 (en) 2009-09-17 2014-07-22 Stephen Perrett Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
CA2783342A1 (en) 2009-12-08 2011-06-16 Depomed, Inc. Gastric retentive pharmaceutical compositions for extended release of polypeptides
JP2013522284A (ja) 2010-03-19 2013-06-13 アプタリス・ファーマ・カナダ・インコーポレイテッド 胃耐性の酵素医薬組成物
GB201006178D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
UY33548A (es) 2010-08-06 2012-02-29 Eurand Pharmaceuticals Inc Formula nutricional predigerida
EA029101B1 (ru) 2010-10-01 2018-02-28 Апталис Фарма Лимитид Составы с низкой дозой панкрелипазы и кишечнорастворимым покрытием
WO2012052853A2 (en) 2010-10-21 2012-04-26 Aptalis Pharma Limited Oral dosing device for administration of medication
GB2492284B (en) 2011-03-27 2013-07-17 Cellresin Tech Llc Cyclodextrin compositions, articles, and methods
RU2602183C2 (ru) 2011-08-08 2016-11-10 Апталис Фарма Лтд. Способ проведения теста на растворение твердых композиций, содержащих пищеварительные ферменты
ES2707211T3 (es) 2013-03-15 2019-04-02 Allergan Pharmaceuticals Int Ltd Proceso para la preparación de una composición que contiene enzimas digestivas y nutrientes adecuada para su administración enteral
WO2015019198A2 (en) 2013-07-22 2015-02-12 Aptalis Pharma S.R.L. High potency pancreatin pharmaceutical compositions
RU2679832C2 (ru) 2013-08-09 2019-02-13 Аллерган Фармасьютикалз Интернэйшнл Лимитед Композиция пищеварительных ферментов, подходящая для энтерального введения
CN106659773A (zh) 2013-11-05 2017-05-10 阿勒根制药国际有限公司 高效的胰酶药物组合物
EP3157568A1 (en) 2014-06-19 2017-04-26 Aptalis Pharma Limited Methods for removing viral contaminants from pancreatic extracts

Also Published As

Publication number Publication date
ES2240559T3 (es) 2005-10-16
KR20030060105A (ko) 2003-07-12
AU2002224843A1 (en) 2002-05-27
CA2428837A1 (en) 2002-05-23
US9259393B2 (en) 2016-02-16
DE60110106T2 (de) 2006-03-02
US20160120815A1 (en) 2016-05-05
US20040101562A1 (en) 2004-05-27
WO2002040045A2 (en) 2002-05-23
DE60110106D1 (de) 2005-05-19
JP2004513645A (ja) 2004-05-13
JP4555981B2 (ja) 2010-10-06
WO2002040045A3 (en) 2002-10-31
ITMI20002456A1 (it) 2002-05-15
US9884025B2 (en) 2018-02-06
EP1335706A2 (en) 2003-08-20
ATE292959T1 (de) 2005-04-15
EP1335706B1 (en) 2005-04-13

Similar Documents

Publication Publication Date Title
IT1319655B1 (it) Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
ATE443752T1 (de) Enzymstabilisierung
EP1478322A4 (en) Beta 2'-OR 3'-HALONUCLEOSIDE
MY129998A (en) Saccharin derivative proteolytic enzyme inhibitors
DK0693281T3 (da) Farmaceutiske fluoxetinformuleringer
IT1260468B (it) Metodo per mantenere l'attivita' di enzimi proteolitici modificati con polietilenglicole
DK0642351T3 (da) Nye farmaceutiske anvendelser af krillenzymer
DE60005017D1 (de) Prodrugs von impdh-inhibierenden carbamaten
WO1999057246A8 (en) Animal cell culture media comprising non-animal or plant-derived nutrients
MY110104A (en) Saccharin derivative proteolytic enzyme inhibitors
EP1319402A4 (en) IgE FORMATION INHIBITORS
ATE431416T1 (de) Enzymatische synthese von deoxyribonucleotiden
DK0414007T3 (da) Hidtil ukendt arginindeiminase, dens fremstillingsmetode og et anti-cancermiddel indeholdende dette enzym som en effektiv ingrediens
EA200300743A1 (ru) Ячмень с низкой липоксигеназной 1 активностью
WO2003099202A3 (en) Beta-secretase inhibitors
EA200001164A1 (ru) КОМБИНАЦИИ ИНГИБИТОРОВ ПРОТЕИН ФАРНЕЗИЛТРАНСФЕРАЗЫ И HMG KoA РЕДУКТАЗЫ И ИХ ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАКА
MY132553A (en) Methods of making hiv-protease inhibitors and intermediates for making hiv-protease inhibitors
AU3719100A (en) Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
ES2181897T3 (es) Composicion enzimatica.
HUP9801439A2 (hu) Béta-D-Galakotpiranozil-D-xilózok alkalmazása bél laktáz kimutatására alkalmas készítmények és oldatok előállításánál, valamint eljárás a vegyületek előállítására
DK1165491T3 (da) LTA4-hydrolase-inhibitorer
AU2002257597A1 (en) Immunomodulating agents from parasitic worms and method for isolation thereof
ATE540104T1 (de) Suspensionskultur von mykobakterien
BR0009636B1 (pt) processo para a preparação de insulina madura ou um derivado de insulina madura.
WO2005034971A3 (en) Antiviral agent